EGFR and non-small cell lung carcinoma: Weiss et al. [72] reported that miR-128b could directly regulate EGFR. The loss of heterozygosity (LOH) of miR-128b occurred frequently in NSCLC and correlated significantly with clinical response and survival after EGFR-TKI.